Intensive Glycemic Control CV Autonomic Neuropathy
Cardiovascular autonomic neuropathy (CAN) risk may be reduced among type 2 diabetes patients undergoing intensive glycemic therapy, according to a study. Investigators examined the effect of intensively treating traditional risk...
Read More